ADVERTISEMENT
ADVERTISEMENT
A vet and technician take a sample from a dog for use in PetDx’s OncoK9 test, which screens cell-free DNA for genomic alterations associated with cancer.
The Pet Health Industry Takes on Canine Cancer
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
The Pet Health Industry Takes on Canine Cancer
The Pet Health Industry Takes on Canine Cancer

Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.

Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.

cell-free

A blood test tube with the label ‘cfDNA Screening–Test’, held in a hand wearing blue gloves.
The Basics and Applications of Cell-Free DNA 
Rebecca Roberts, PhD | Nov 8, 2023 | 5 min read
Found circulating in peripheral blood, scientists use cell-free DNA (cfDNA) to assess genetic abnormalities, infections, cancer, transplant rejection, and cardiovascular disease.
The Scientist Speaks - Repurposing Living Systems to Fight a Pandemic
The Scientist | Sep 29, 2020 | 1 min read
Episode 9
Simplifying Protein Expression with myTXTL
The Scientist | Sep 15, 2020 | 1 min read
Discover the advantages of protein production using the myTXTL cell-free expression system
Combating COVID-19 with Cell-Free Expression
The Scientist | Aug 19, 2020 | 6 min read
Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.
An Introduction to Cell-Free Protein Expression
The Scientist | Jul 16, 2020 | 1 min read
Simplify protein production with the myTXTL cell-free expression system
cell-free mitochondria plasma cancer
Researchers Find Cell-Free Mitochondria Floating in Human Blood
Katarina Zimmer | Feb 6, 2020 | 5 min read
The functional, respiring organelles appear to be present in the blood of healthy people, but their function is yet unclear.
ADVERTISEMENT